Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UQCRFS1P2 is identified as a pseudogene related to the ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 gene[1][3][7]. Pseudogenes such as UQCRFS1P2 do not encode functional proteins, and are generally considered non-coding genomic sequences. While some pseudogenes have been found to regulate their parent gene expression through RNA-mediated interactions—such as acting as microRNA decoys or being transcribed into regulatory RNAs—there is no evidence that UQCRFS1P2 has a defined function or serves as a therapeutic or diagnostic target[5]. As such, it is not considered a true molecular target (such as a receptor, enzyme, or transporter), but rather a genetic relic with no known clinical or molecular function.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 pseudogene 2 (UQCRFS1P2).